Medical Developments International Limited
MDDVF
$0.3206
-$0.187-36.84%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.12% | -8.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.12% | -8.15% | |||
| Cost of Revenue | 2.12% | -20.31% | |||
| Gross Profit | 2.12% | -3.81% | |||
| SG&A Expenses | 2.12% | 12.63% | |||
| Depreciation & Amortization | 2.12% | -3.19% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.12% | 2.10% | |||
| Operating Income | -2.12% | -183.93% | |||
| Income Before Tax | -2.14% | -145.21% | |||
| Income Tax Expenses | 2.09% | 354.76% | |||
| Earnings from Continuing Operations | -2.12% | -166.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.12% | -166.57% | |||
| EBIT | -2.12% | -183.93% | |||
| EBITDA | -341.47% | -97.07% | |||
| EPS Basic | 0.00% | -166.67% | |||
| Normalized Basic EPS | 0.00% | -150.00% | |||
| EPS Diluted | 0.00% | -166.67% | |||
| Normalized Diluted EPS | 0.00% | -150.00% | |||
| Average Basic Shares Outstanding | 0.00% | 4.89% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||